Brought to you by:
Jamie Bell
CGuard Prime carotid stent gains US and European approvals for stroke prevention
InspireMD has been granted premarket approval (PMA) from the Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the U.S.—news that follows the company’s recent announcement of CE-mark approval under the European Medical Device Regulation (MDR).…
Long-term VQI-VISION analysis sheds light on PVI versus bypass in aortoiliac occlusive disease
Today’s Plenary Session 4—Hosted in Great Hall A, First Floor from 10:45 a.m.–12 p.m.—will feature a presentation of five-year findings from the VQI-VISION database indicating that aortobifemoral bypass (ABF) remains a more durable long-term treatment option compared to endovascular intervention…
Experts to examine ‘evolving landscape’ of vascular intervention in PE management
A number of topics relating to pulmonary embolism (PE) management—including lytic therapy versus thrombectomy, risk stratification and device selection—will feature this afternoon during an educational session. Taking place from 3:15–4.45 p.m. on the Second Floor (Room 217–219) at the 2025…
CEA ‘remains useful and relevant’ in era of improving medical therapy
Findings from a retrospective analysis delivered at the recent European Society for Vascular Surgery (ESVS) annual meeting (Sept. 24–27) in Kraków, Poland, provide evidence that—for symptomatic carotid artery stenosis patients—endarterectomy “remains a useful and relevant intervention in the era of…